Ying Zou Selected Research

His(5)-Trp(7)-Tyr(8)- LHRH

1/2013	In vitro apoptosis effects of GnRHII on endometrial stromal cells from patients with endometriosis.
1/2013	Effect of GnRH-II on the ESC proliferation, apoptosis and VEGF secretion in patients with endometriosis in vitro.
5/2010	Effect of GnRH II and GnRH I on secretion of VEGF by eutopic and ectopic endometrial stromal cells of endometriosis patients.
9/2009	[Effect of GnRH-II on VEGF secreted by stromal cells from endometrium of endometriosis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying Zou Research Topics

Disease

24	Neoplasms (Cancer) 05/2022 - 01/2003
10	Inflammation (Inflammations) 04/2022 - 01/2014
8	Ulcerative Colitis 03/2016 - 04/2012
6	Colorectal Neoplasms (Colorectal Cancer) 02/2022 - 03/2015
6	Colitis 01/2021 - 01/2014
5	Breast Neoplasms (Breast Cancer) 11/2021 - 10/2016
5	Endometriosis 01/2013 - 09/2009
4	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 05/2007
3	Pain (Aches) 04/2022 - 08/2017
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 01/2015
3	Neoplasm Metastasis (Metastasis) 06/2020 - 03/2015
3	Hypoxia (Hypoxemia) 01/2019 - 10/2003
3	Carcinogenesis 12/2016 - 01/2013
2	Atopic Dermatitis (Atopic Eczema) 04/2022 - 01/2022
2	Hypertension (High Blood Pressure) 03/2022 - 02/2006
2	Carcinoma (Carcinomatosis) 01/2022 - 08/2021
2	Bites and Stings (Sting) 01/2022 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2021
2	Ovarian Neoplasms (Ovarian Cancer) 11/2021 - 01/2020
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 09/2021 - 04/2018
2	Disease Progression 01/2021 - 12/2020
2	COVID-19 10/2020 - 09/2020
2	Contact Dermatitis (Eczema, Contact) 08/2020 - 04/2012
2	Hypersensitivity (Allergy) 08/2020 - 03/2016
2	Melanoma (Melanoma, Malignant) 06/2020 - 12/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2019
2	Cognitive Dysfunction 01/2020 - 01/2019
2	Overweight 01/2020 - 01/2018
2	Weight Loss (Weight Reduction) 01/2020 - 10/2015
2	Body Weight (Weight, Body) 01/2020 - 04/2005
2	Stomach Neoplasms (Stomach Cancer) 10/2019 - 07/2017
2	Retinal Neovascularization 10/2019 - 04/2005
2	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 10/2016
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 08/2017 - 12/2014
2	Genomic Instability 01/2017 - 10/2014
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2017 - 12/2016
2	Coronary Disease (Coronary Heart Disease) 05/2016 - 01/2016
2	Prostatic Neoplasms (Prostate Cancer) 03/2016 - 01/2013
1	Dyslipidemias (Dyslipidemia) 12/2022
1	Critical Illness (Critically Ill) 03/2022
1	Wallerian Degeneration 03/2022
1	Peripheral Nerve Injuries 03/2022
1	Adenoma (Adenomas) 02/2022
1	Adenocarcinoma 02/2022

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2003
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2019 - 10/2003
6	Pharmaceutical PreparationsIBA 12/2022 - 11/2014
6	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2016
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2014
5	CytokinesIBA 01/2021 - 01/2013
5	baicalinIBA 10/2015 - 04/2012
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2017 - 05/2004
4	His(5)-Trp(7)-Tyr(8)- LHRHIBA 01/2013 - 09/2009
3	fibrin fragment D (D-dimer)IBA 03/2022 - 05/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2018
3	LipidsIBA 09/2021 - 01/2018
3	MicroRNAs (MicroRNA)IBA 10/2019 - 10/2016
2	InterferonsIBA 01/2022 - 01/2020
2	Shen-FuIBA 01/2022 - 01/2021
2	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2013
2	dupilumabIBA 01/2022 - 01/2021
2	Gefitinib (Iressa)FDA Link 01/2022 - 01/2021
2	Mitochondrial DNA (mtDNA)IBA 01/2022 - 01/2016
2	Dextran SulfateIBA 01/2021 - 01/2014
2	CateninsIBA 01/2021 - 01/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2020 - 11/2014
2	ChitosanIBA 01/2020 - 01/2018
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 10/2016
2	Transcription Factors (Transcription Factor)IBA 10/2019 - 04/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2019 - 10/2014
2	CurcuminIBA 12/2018 - 09/2017
2	LycopeneIBA 08/2017 - 12/2014
2	Dextrans (Dextran)FDA Link 12/2016 - 01/2014
2	Huangqin-TangIBA 12/2016 - 01/2015
2	Serotonin (5 Hydroxytryptamine)IBA 03/2016 - 05/2003
2	AgarIBA 01/2016 - 12/2004
2	AcidsIBA 01/2015 - 04/2012
2	Mesalamine (Mesalazine)FDA LinkGeneric 01/2015 - 01/2014
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2013 - 05/2010
2	GenisteinIBA 04/2005 - 10/2003
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 12/2022
1	SubtilisinIBA 12/2022
1	IodineIBA 05/2022
1	CannabidiolIBA 04/2022
1	Aspartame (NutraSweet)IBA 04/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2022
1	NocodazoleIBA 03/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2022
1	Angiotensin Receptor AntagonistsIBA 03/2022
1	Calcibiotic Root Canal SealerIBA 02/2022
1	TOR Serine-Threonine KinasesIBA 02/2022
1	Mitogen-Activated Protein KinasesIBA 02/2022
1	Ethidium (Ethidium Bromide)IBA 01/2022

Therapy/Procedure

12	Therapeutics 11/2021 - 05/2004
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 12/2016
3	Aftercare (After-Treatment) 05/2021 - 01/2019
2	Lasers (Laser) 05/2021 - 10/2003
2	Perioperative Period 04/2018 - 03/2015
2	Drug Therapy (Chemotherapy) 01/2017 - 01/2016